121 related articles for article (PubMed ID: 12459370)
21. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
[TBL] [Abstract][Full Text] [Related]
22. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
Janjan NA; Crane CN; Feig BW; Cleary K; Dubrow R; Curley SA; Ellis LM; Vauthey J; Lenzi R; Lynch P; Wolff R; Brown T; Pazdur R; Abbruzzese J; Hoff PM; Allen P; Brown B; Skibber J
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):713-8. PubMed ID: 10837955
[TBL] [Abstract][Full Text] [Related]
23. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
25. The usefulness of immunohistochemical evaluation of dihydropyrimidine dehydrogenase for rectal cancer treated with preoperative radiotherapy.
Komuro Y; Watanabe T; Tsuno N; Kitayama J; Inagaki N; Nishida M; Nagawa H
Hepatogastroenterology; 2003; 50(52):906-11. PubMed ID: 12845947
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
[TBL] [Abstract][Full Text] [Related]
28. [Preoperative radiation with chemotherapy for rectal cancer: its impact on downstaging of disease and the role of endorectal ultrasound].
Juska P; Pavalkis D; Pranys D
Medicina (Kaunas); 2004; 40(1):46-53. PubMed ID: 14764982
[TBL] [Abstract][Full Text] [Related]
29. Induction therapy for rectal carcinoma.
Busse PM; Ng A; Recht A
Semin Surg Oncol; 1998 Sep; 15(2):120-5. PubMed ID: 9730418
[TBL] [Abstract][Full Text] [Related]
30. Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
Minsky BD; Cohen AM; Enker WE; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass J; Conti J
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):289-95. PubMed ID: 9069299
[TBL] [Abstract][Full Text] [Related]
31. [The importance of delay in patients with tumors exemplified by pretreatment of locally advanced rectal carcinoma].
Gretschel S; Rau B; Wust P; Riess H; Schlag PM
Strahlenther Onkol; 2000 Oct; 176(10):448-51. PubMed ID: 11068588
[TBL] [Abstract][Full Text] [Related]
32. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
33. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
34. High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Kim K; Chie EK; Wu HG; Kim SG; Lee SH; Kang GH; Hyun CL; Ha SW
Int J Colorectal Dis; 2011 Aug; 26(8):1019-23. PubMed ID: 21424389
[TBL] [Abstract][Full Text] [Related]
35. KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials.
Kim SY; Shim EK; Yeo HY; Baek JY; Hong YS; Kim DY; Kim TW; Kim JH; Im SA; Jung KH; Chang HJ
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):201-7. PubMed ID: 22672749
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer.
Watwe V; Javle M; Lawrence D; Groth J; Iyer R; El-Hajjar D; Geradts J
Am J Clin Oncol; 2005 Dec; 28(6):560-4. PubMed ID: 16317264
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation.
Li S; Kim JS; Kim JM; Cho MJ; Yoon WH; Song KS; Yeo SG; Kim JS
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):705-12. PubMed ID: 16690221
[TBL] [Abstract][Full Text] [Related]
38. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
Mawdsley S; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Osborne M; Livingstone JI; MacDonald P; Mitchell IC; Meyrick-Thomas J; Northover JM; Windsor A; Novell R; Wallace M
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):745-52. PubMed ID: 16199310
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer.
Movsas B; Diratzouian H; Hanlon A; Cooper H; Freedman G; Konski A; Sigurdson E; Hoffman J; Meropol NJ; Weiner LM; Coia L; Lanciano R; Stein J; Kister D; Eisenberg B
Am J Clin Oncol; 2006 Oct; 29(5):435-41. PubMed ID: 17023775
[TBL] [Abstract][Full Text] [Related]
40. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
